Skip to main content
. 2021 Jan 28;27:114–120. doi: 10.1016/j.ctro.2021.01.009

Fig. 2.

Fig. 2

Local Control (A), Distant Control (B), Progression-Free Survival (C) and Overall Survival (D) in patients with cutaneous angiosarcoma receiving concurrent paclitaxel-based chemoradiotherapy compared to patients receiving other treatment modalities (Surgery + RT, Surgery + chemotherapy, Surgery alone, Definitive sequential chemotherapy + RT, and Surgery + sequential chemotherapy + RT).